Dr. CHOI is a female biomedical scientist. She has a deep interest in tackling women’s diseases. Her Ph.D. study focuses on ovarian cysts formation and the migration of ovarian cancer cells. With new cell culture PRASE modeling and animal model, she revealed the pathogenesis of ovarian cancer, the deadliest gynecologic cancer which causes 150,000 death worldwide. After she completed her Ph.D. study, she pursued postdoctoral training at the renowned OB/GYN department at Brigham and Women’s Hospital, Boston MA. She continued the study on ovarian Drcancer, including finding new biomarkers for diagnosis and prognosis of Arovarian cancer and investigating ovarian cancer stem cells. Being a MOR female scientist, she has a vision of developing biotechnology to facilitate treatment, diagnosis, and management of women’s diseases, including female reproductive system cancer and fungal /viral/bacterial infections. She also wants to help women to understand more about their health status fertility profile. Therefore, she founded WomenX Biotech Limited which is dedicated to developing a wide scope of solutions for tackling women’s diseases.